-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Initiates Coverage On Benitec Biopharma with Outperform Rating, Announces Price Target of $16

Benzinga·07/28/2026 12:49:49
Listen to the news
Wedbush analyst Yun Zhong initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Outperform rating and announces Price Target of $16.